Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Thomas Davis, M.D., Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc., will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, October 22nd, at 2:00 p.m. EDT in New York City.
A live webcast of the presentation will be available on the “Presentations” page of the “Investors” section of Celldex’s website at http://www.celldextherapeutics.com and will be archived for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.
Contacts:
Anthony S. Marucci, 781-433-0771
President
and CEO
or
Celldex Therapeutics, Inc.
Avery W. Catlin,
781-433-0771
Chief Financial Officer
IR@celldextherapeutics.com
or
For
Media:
BMC Communications Group
Matthew Driscoll,
212-477-9007 x20
mdriscoll@bmccommunications.com